Small-molecule activator of UNC-51-like kinase 1 (ULK1) that induces cytoprotective autophagy for Parkinson's disease treatment
UNC-51-like kinase 1 (ULK1), the yeast Atg1 ortholog, is the sole serine-threonine kinase
and initiating enzyme in autophagy, which may be regarded as a target in Parkinson's …
and initiating enzyme in autophagy, which may be regarded as a target in Parkinson's …
Pharmacological intervention to restore connectivity deficits of neuronal networks derived from ASD patient iPSC with a TSC2 mutation
M Alsaqati, VM Heine, AJ Harwood - Molecular autism, 2020 - Springer
Background Tuberous sclerosis complex (TSC) is a rare genetic multisystemic disorder
resulting from autosomal dominant mutations in the TSC1 or TSC2 genes. It is characterised …
resulting from autosomal dominant mutations in the TSC1 or TSC2 genes. It is characterised …
The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target
ST Xue, K Li, Y Gao, LY Zhao, Y Gao, H Yi, JD Jiang… - Autophagy, 2020 - Taylor & Francis
Although macroautophagy/autophagy is involved in hepatocellular carcinoma (HCC)
initiation and development and has been identified as a mechanism of HCC therapy …
initiation and development and has been identified as a mechanism of HCC therapy …
Mechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapy
J Zhang, G Wang, Y Zhou, Y Chen, L Ouyang… - Cellular and Molecular …, 2018 - Springer
Autophagy is an evolutionarily conserved, multi-step lysosomal degradation process for the
clearance of damaged or superfluous proteins and organelles. Accumulating studies have …
clearance of damaged or superfluous proteins and organelles. Accumulating studies have …
Autophagy modulation in cancer therapy: Challenges coexist with opportunities
Y Wu, A Wang, G Feng, X Pan, W Shuai, P Yang… - European Journal of …, 2024 - Elsevier
Autophagy, a crucial intracellular degradation process facilitated by lysosomes, plays a
pivotal role in maintaining cellular homeostasis. The elucidation of autophagy key genes …
pivotal role in maintaining cellular homeostasis. The elucidation of autophagy key genes …
Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy
R Zhao, J Fu, L Zhu, Y Chen, B Liu - Journal of hematology & oncology, 2022 - Springer
Non-coding RNAs (ncRNAs) have been defined as a class of RNA molecules transcribed
from the genome but not encoding proteins, such as microRNAs, long non-coding RNAs …
from the genome but not encoding proteins, such as microRNAs, long non-coding RNAs …
[HTML][HTML] Small molecules targeting programmed cell death in breast cancer cells
Targeted chemotherapy has become the forefront for cancer treatment in recent years. The
selective and specific features allow more effective treatment with reduced side effects. Most …
selective and specific features allow more effective treatment with reduced side effects. Most …
Enhanced VEGF secretion and blood–brain barrier disruption: Radiation‐mediated inhibition of astrocyte autophagy via PI3K‐AKT pathway activation
S Zhang, M Li, Y Qiu, J Wu, X Xu, Q Ma, Z Zheng, G Lu… - Glia, 2024 - Wiley Online Library
Radiation‐induced damage to the blood–brain barrier (BBB) is the recognized pathological
basis of radiation‐induced brain injury (RBI), a side effect of head and neck cancer …
basis of radiation‐induced brain injury (RBI), a side effect of head and neck cancer …
Discovery of a novel dual-target inhibitor of ERK1 and ERK5 that induces regulated cell death to overcome compensatory mechanism in specific tumor types
G Wang, Y Zhao, Y Liu, D Sun, Y Zhen… - Journal of Medicinal …, 2020 - ACS Publications
ERK1 and ERK5 are proposed to have pivotal roles in several types of cancer. Under some
circumstance, ERK5 may provide a common bypass route, which rescues proliferation upon …
circumstance, ERK5 may provide a common bypass route, which rescues proliferation upon …
Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3
R Fu, P Yang, Z Li, W Liu, S Amin, Z Li - Cell death & disease, 2019 - nature.com
Colorectal cancer (CRC) is a common malignant gastrointestinal tumor with high mortality
worldwide. Drug resistance and cytotoxicity to normal cells are the main causes of …
worldwide. Drug resistance and cytotoxicity to normal cells are the main causes of …